Putnam Investments’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,488	Closed	-$338K	–	1201
2022 Q2	$338K	Buy	+10,488	New	+$352K	﹤0.01%	1061
2020 Q3	–	Sell	-47,983	Closed	-$2M	–	890
2020 Q2	$2M	Buy	+47,983	New	+$1.74M	﹤0.01%	678
2018 Q2	–	Sell	-9,562	Closed	-$1.54M	–	1174
2018 Q1	$1.54M	Buy	9,562 +3,579	+60%	+$608K	﹤0.01%	770
2017 Q4	$986K	Buy	+5,983	New	+$580K	﹤0.01%	890
2017 Q2	–	Sell	-6,995	Closed	-$497K	–	1268
2017 Q1	$497K	Sell	6,995 -1,629	-19%	-$95.4K	﹤0.01%	1109
2016 Q4	$440K	Buy	8,624 +261	+3%	+$12.3K	﹤0.01%	1139
2016 Q3	$386K	Sell	8,363 -11,067	-57%	-$450K	﹤0.01%	1158
2016 Q2	$586K	Sell	19,430 -124	-0.6%	-$4.13K	﹤0.01%	1176
2016 Q1	$627K	Buy	19,554 +106	+0.5%	+$3.73K	﹤0.01%	1200
2015 Q4	$1.13M	Sell	19,448 -358	-2%	-$17.7K	﹤0.01%	1130
2015 Q3	$838K	Buy	19,806 +500	+3%	+$30.8K	﹤0.01%	1214
2015 Q2	$1.41M	Buy	+19,306	New	+$1.24M	﹤0.01%	1148